Yamaguchi University · University Hospital

Research keywordsEGFR-mutant lung adenocarcinoma・PD-L1 expression・hepatocellular carcinoma vaccine・perioperative cancer vaccines・roxadustat adverse events・hypothyroidism signal detection・advanced pancreatic cancer・multi-HLA-binding peptides

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Prognostic impact of PD-L1 expression in surgically resected EGFR-mutant lung adenocarcinoma: A real-world database study in Japan (CReGYT-01 EGFR study).2025 · International journal of cancer
• Impact of central nervous system metastasis after complete resection of lung adenocarcinomas harboring common EGFR mutation - A real-world database study in Japan: The CReGYT-01 EGFR study.2024 · European journal of cancer (Oxford, England : 1990)
• A phase I study of a novel therapeutic vaccine as perioperative treatment for patients with surgically resectable hepatocellular carcinoma: The YCP02 trial.2023 · Hepatology research : the official journal of the Japan Society of Hepatology
• Disproportionality analysis on hypothyroidism with roxadustat using the japanese adverse drug event database.2023 · Journal of clinical pharmacology

• Official profile